Normality tables in the Spanish population for psychometric tests used in the diagnosis of minimal hepatic encephalopathy;Tablas de normalidad de la población española para los tests psicométricos utilizados en el diagnóstico de la encefalopatía hepática mínima

Medicina Clinica

Volumn 127, Issue 7, 2006, Pages 246-249

  Romero Gómez, Manuel ^a   Córdoba, Juan ^b   Jover, Rodrigo ^c   Del Olmo, Juan ^d   Ferná, Ana ^e   Flavià, Montse ^b   Compañy, Luis ^c   Poveda, María José ^c   Felipo, Vicente ^f  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^e UNIVERSITY OF SEVILLE   (Spain)

^f Fund Valenciana de Invest Biomed   (Spain)

Author keywords

Digit symbol test; Line drawing test; Number connection test; Serial dotting

Indexed keywords

ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC TEST; EDUCATION; HEPATIC ENCEPHALOPATHY; HOSPITALIZATION; HUMAN; MULTIPLE LINEAR REGRESSION ANALYSIS; NORMAL HUMAN; PSYCHOLOGIC TEST; PSYCHOMETRY; QUALITY OF LIFE; SCORING SYSTEM; SEX ROLE; SPAIN; STUDENT T TEST;

EID: 33748413047     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13091264     Document Type: Article

References (12)

1. Groeneweg M, Quero JC, De Bruijn I, Hartmann IJ, Essink-Bot ML, Hop WC, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology. 1998;28:45-9.
2. Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology. 2004;39:739-45.
3. Romero-Gómez M, Boza F, García-Valdecasas MS, García E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol. 2001;96:2718-23.
4. Romero-Gomez M, Grande L, Camacho I. Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy. Hepatology. 2004;39:939-43.
5. Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol. 2001;34:768-73.
6. Amodio P, Wenin H, Del Piccolo F, Mapelli D, Montagnese S, Pellegrini A, et al. Variability of trail making test, symbol digit test and line trait test in normal people. A normative study taking into account age-dependent decline and sociobiological variables. Aging Clin Exp Res. 2002;14:117-31.
7. Romero-Gómez M, Grande L, Camacho I, Benitez S, Irles JA, Castro M. Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy. J Hepatol. 2002;37:781-7.
8. Romero Gómez M, Bautista JD, Grande L, Ramos Guerrero RM, Sánchez Muñoz D. Nuevos conceptos en la fisiopatología de la encefalopatía hepática y perspectivas terapáuticas. Gastroenterol Hepatol. 2004;27 Supl 1:40-8.
9. Erceg S, Monfort P, Hernândez-Viadel M, Rodrigo R, Montoliu C, Felipo V. Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunts. Hepatology. 2005;41:299-306.
10. Montagnese S, Amodio P, Morgan MY. Methods for diagnosing hepatic encephalopathy in patients with cirrhosis: a multidimensional approach. Metab Brain Dis. 2004;19:281-312.
11. Jover R, Company L, Gutiérrez A, Zapater P, Pérez-Serra J, Girona E, et al. Minimal hepatic encephalopathy and extrapyramidal signs in patients with cirrhosis. Am J Gastroenterol. 2003;98:1599-604.
12. Ortiz M, Jacas C, Cordoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol. 2005;42 Suppl 1:45-53.